Advertisement
BIOX vs UAN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOX is a Hold and UAN is a Buy.
BIOX in downward trend: 10-day moving average moved below 50-day moving average on September 24, 2026
The 10-day moving average for BIOX crossed bearishly below the 50-day moving average on September 24, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
BIOX moved below its 50-day moving average on September 24, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIOX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for BIOX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where BIOX advanced for three days, in 181 of 237 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
BIOX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.246) is normal, around the industry mean (-0.286). P/E Ratio (-0.293) is within average values for comparable stocks, (8.446). Projected Growth (PEG Ratio) (1.236) is also within normal values, averaging (0.867). Dividend Yield (0.000) settles around the average of (0.127) among similar stocks. BIOX's P/S Ratio (0.103) is slightly lower than the industry average of (1.476).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. BIOX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BIOX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.
UAN in +0.79% Uptrend, advancing for three consecutive days on October 21, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where UAN advanced for three days, in 234 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for UAN just turned positive on October 14, 2026. Looking at past instances where UAN's MACD turned positive, the stock continued to rise in 31 of 43 cases over the following month. The odds of a continued upward trend are 72%.
The Aroon Indicator entered an Uptrend today. In 173 of 244 cases where UAN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
Bearish Trend Analysis
The 10-day RSI Indicator for UAN moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 29 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 64 cases where UAN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 62%.
The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UAN as a result. In 52 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 60%.
UAN moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for UAN crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
UAN broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 17 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.
The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.815) is normal, around the industry mean (-0.286). P/E Ratio (8.261) is within average values for comparable stocks, (8.446). Projected Growth (PEG Ratio) (0.450) is also within normal values, averaging (0.867). Dividend Yield (0.194) settles around the average of (0.127) among similar stocks. P/S Ratio (2.073) is also within normal values, averaging (1.476).
The Tickeron SMR rating for this company is 21 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. UAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
BIOX | UAN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 68 | 33 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 56 Fair valued | 19 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 17 | |
SMR RATING 1..100 | 95 | 21 | |
PRICE GROWTH RATING 1..100 | 91 | 43 | |
P/E GROWTH RATING 1..100 | 18 | 69 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UAN's Valuation (19) in the Chemicals Agricultural industry is somewhat better than the same rating for BIOX (56) in the Financial Conglomerates industry. This means that UAN’s stock grew somewhat faster than BIOX’s over the last 12 months.
UAN's Profit vs Risk Rating (17) in the Chemicals Agricultural industry is significantly better than the same rating for BIOX (100) in the Financial Conglomerates industry. This means that UAN’s stock grew significantly faster than BIOX’s over the last 12 months.
UAN's SMR Rating (21) in the Chemicals Agricultural industry is significantly better than the same rating for BIOX (95) in the Financial Conglomerates industry. This means that UAN’s stock grew significantly faster than BIOX’s over the last 12 months.
UAN's Price Growth Rating (43) in the Chemicals Agricultural industry is somewhat better than the same rating for BIOX (91) in the Financial Conglomerates industry. This means that UAN’s stock grew somewhat faster than BIOX’s over the last 12 months.
BIOX's P/E Growth Rating (18) in the Financial Conglomerates industry is somewhat better than the same rating for UAN (69) in the Chemicals Agricultural industry. This means that BIOX’s stock grew somewhat faster than UAN’s over the last 12 months.
| BIOX | UAN | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 81% | 1 day ago 69% |
| Stochastic ODDS (%) | 1 day ago 69% | 1 day ago 63% |
| Momentum ODDS (%) | N/A | 1 day ago 60% |
| MACD ODDS (%) | N/A | 1 day ago 72% |
| TrendWeek ODDS (%) | 1 day ago 86% | 1 day ago 61% |
| TrendMonth ODDS (%) | 1 day ago 87% | 1 day ago 58% |
| Advances ODDS (%) | 11 days ago 76% | 2 days ago 73% |
| Declines ODDS (%) | 2 days ago 87% | 4 days ago 58% |
| BollingerBands ODDS (%) | 1 day ago 82% | 1 day ago 71% |
| Aroon ODDS (%) | 1 day ago 87% | 2 days ago 71% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BIOX’s FA Score shows that 1 FA rating(s) are green while UAN’s FA Score has 3 green FA rating(s).
- BIOX’s FA Score: 1 green, 4 red.
- UAN’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BIOX’s TA Score shows that 4 TA indicator(s) are bullish while UAN’s TA Score has 3 bullish TA indicator(s).
- BIOX’s TA Score: 4 bullish, 4 bearish.
- UAN’s TA Score: 3 bullish, 7 bearish.
Price Growth
BIOX (@Chemicals: Agricultural) experienced а -13.42% price change this week, while UAN (@Chemicals: Agricultural) price change was -5.29% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Agricultural industry was -4.57%. For the same industry, the average monthly price growth was -19.38%, and the average quarterly price growth was -17.70%.
Reported Earning Dates
BIOX is expected to report earnings on Nov 11, 2026.
UAN is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Chemicals: Agricultural (-4.57% weekly)The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.
Advertisement